Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy

Background: Among patients with non-small cell lung cancer (NSCLC), we compared the progression-free survival (PFS) and proportion of acquisition of T790M mutation of the epidermal growth receptor gene (EGFR) after first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Inomata, Minehiko, Azechi, Kenji, Takata, Naoki, Hayashi, Kana, Tokui, Kotaro, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Tobe, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759886/
https://www.ncbi.nlm.nih.gov/pubmed/33255696
http://dx.doi.org/10.3390/diagnostics10121006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759886/
https://www.ncbi.nlm.nih.gov/pubmed/33255696
http://dx.doi.org/10.3390/diagnostics10121006

Ejemplares similares